NewAmsterdam Pharma's obicetrapib lowers LDL-C in Phase 3 trials, showing promise as a CETP inhibitor. Read more on NAMS ...

This $330 smartwatch can outlast its competitors in battery life and fitness features, but may fall short on software updates ...

Investment in robotics may be substantial, but long-term benefits of automation include lower labour costs and more ...

Sea Limited (NYSE: SE) has been one of the most interesting tech companies to watch for the last few years. At one point, it ...

The Dell UtraSharp 32 4K Thunderbolt Hub Monitor is a solid value. It offers a crisp, vivid IPS Black 4K display for under $1 ...

Keeping up with everything going on around baseball is tough enough in the best of times, but it's more true during Spring ...

Nunez has an unusually short stride for a hard thrower, falls to the first base side while spinning off his landing heel and ...

Amid a torrent of troubling headlines, FT Edit brings you eight things to look forward to over the coming months ...

Now, Connor Teskey is earning his appointment as eventual successor to Bruce Flatt at Brookfield Asset Management by staking ...

The numbers are out for the 2025 MLB season, and if you've been a Houston Astros fan for the last eight years or so, they are ...

Many stocks in the healthcare sector have trailed the wider markets, but are there pockets of opportunity? TD Asset Management's Ram Sampath discusses.

A personal trainer tells Harry Bullmore how you can easily build a fit and functional body, improve your posture and enhance ...